gvtcx

Automated DNA & RNA quality assessment electrophoresis system

MHRA Buyer Organisation Published 10 Mar 2021 Contracts Finder

key details

Value£39,088
Statuscomplete
Category (CPV) 38000000
RegionLondon
Deadline12 Feb 2021
Contract start20 Mar 2021
Contract end20 Mar 2026
Procedureopen
SME suitableYes
OCIDocds-b5fd17-9e7a5b2a-c6ad-4be3-badd-725afdc3f237

Award

SupplierValueDateStatus
Agilent Technologies LDA UK Ltd £39,088 10 Mar 2021 active

description

The Agency intends to purchase an automated electrophoresis system for the quality control of DNA and RNA samples, including genomic DNA, cell-free DNA, DNA libraries for sequencing, eukaryotic total RNA and mRNA; and prokaryotic total RNA. The system should enable the analysis of small volumes (≤3ul), does not need the capacity for high throughput, but should prevent sample to sample contamination and carryover. The system should provide data on quantification and sample integrity (molecular weight, size distribution). Sample detection of genomic DNA and total RNA should be to 0.1ng/ul. Sample detection of cell-free DNA should be <50pg/ul.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
10 Mar 2021 Award (award) · 0a54d7de-3afe-4e78-bf93-14afcfa173a4-419189

more from MHRA Buyer Organisation

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.